A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer.
作者信息
Ruan Ji
机构信息
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
出版信息
AIMS Genet. 2019 Sep 30;6(4):67-69. doi: 10.3934/genet.2019.4.67. eCollection 2019.
Abstract
摘要
相似文献
1
A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer.一种用于预测II/III期结肠癌术后复发的基于环状RNA的强大预后特征。
AIMS Genet. 2019 Sep 30;6(4):67-69. doi: 10.3934/genet.2019.4.67. eCollection 2019.
2
Establishment of a 12-gene expression signature to predict colon cancer prognosis.建立一个用于预测结肠癌预后的12基因表达特征。
PeerJ. 2018 Jun 14;6:e4942. doi: 10.7717/peerj.4942. eCollection 2018.
3
Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.鉴定一种十六种微小RNA特征作为II期和III期结肠癌的预后生物标志物。
Oncotarget. 2017 Sep 23;8(50):87837-87847. doi: 10.18632/oncotarget.21237. eCollection 2017 Oct 20.
4
Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.基于术后循环肿瘤细胞的预后模型可以预测II-III期结直肠癌患者较差的无肿瘤复发生存率。
J Cancer. 2019 Jul 25;10(19):4552-4563. doi: 10.7150/jca.30512. eCollection 2019.
5
A robust gene signature for the prediction of early relapse in stage I-III colon cancer.用于预测 I-III 期结肠癌早期复发的稳健基因标志物。
Mol Oncol. 2018 Apr;12(4):463-475. doi: 10.1002/1878-0261.12175. Epub 2018 Feb 16.
6
Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.基于 5-氟尿嘧啶的辅助化疗治疗 II 期和 III 期结肠癌患者肿瘤复发的基因表达特征。
Int J Cancer. 2013 Mar 1;132(5):1090-7. doi: 10.1002/ijc.27747. Epub 2012 Aug 12.
7
Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.基质VCAN表达作为II-III期结肠癌疾病复发的潜在预后生物标志物。
Carcinogenesis. 2016 Sep;37(9):878-887. doi: 10.1093/carcin/bgw069. Epub 2016 Jun 9.
8
A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer.一种用于II/III期结肠癌患者术后复发的新型预后预测工具。
Cancer Commun (Lond). 2019 Oct 1;39(1):52. doi: 10.1186/s40880-019-0397-1.
9
Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer.采用转录-逆转录协同法检测腹膜灌洗液中癌胚抗原mRNA表明，II期和III期结肠癌患者预后较差。
Surgery. 2015 Feb;157(2):322-30. doi: 10.1016/j.surg.2014.09.015. Epub 2014 Oct 11.
10
Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.在II期和III期结肠癌中，KCNQ1表达缺失是疾病复发的一个强有力的预后因素。
Br J Cancer. 2016 Dec 6;115(12):1565-1574. doi: 10.1038/bjc.2016.376. Epub 2016 Nov 17.
引用本文的文献
1
Circular RNA hsa_circ_0064559 affects tumor cell growth and progression of colorectal cancer.环状 RNA hsa_circ_0064559 影响结直肠癌细胞的生长和进展。
World J Surg Oncol. 2023 Jun 7;21(1):171. doi: 10.1186/s12957-023-03050-5.
2
Construction of a prognostic risk model of colorectal adenocarcinoma through integrated analysis of RNA-binding proteins.通过RNA结合蛋白的综合分析构建结直肠癌的预后风险模型
Transl Cancer Res. 2021 May;10(5):1962-1974. doi: 10.21037/tcr-21-40.
本文引用的文献
1
A circRNA signature predicts postoperative recurrence in stage II/III colon cancer.环状 RNA 特征可预测 II/III 期结肠癌术后复发。
EMBO Mol Med. 2019 Oct;11(10):e10168. doi: 10.15252/emmm.201810168. Epub 2019 Sep 2.
2
A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma.环状 LINC-PINT 编码的肽抑制胶质母细胞瘤中的致癌转录延伸。
Nat Commun. 2018 Oct 26;9(1):4475. doi: 10.1038/s41467-018-06862-2.
3
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率：GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
4
Differential incidence trends of colon and rectal cancers in Hong Kong: an age-period-cohort analysis.香港结肠癌和直肠癌的发病趋势差异：一项年龄-时期-队列分析。
Cancer Commun (Lond). 2018 Jun 28;38(1):42. doi: 10.1186/s40880-018-0311-2.
5
Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1.环状 RNA circ-Ccnb1 抑制突变型 p53 增强的乳腺癌进展。
Cell Death Differ. 2018 Dec;25(12):2195-2208. doi: 10.1038/s41418-018-0115-6. Epub 2018 May 23.
6
Precision medicine becomes reality-tumor type-agnostic therapy.精准医疗成为现实——肿瘤类型不可知的治疗方法。
Cancer Commun (Lond). 2018 Mar 31;38(1):6. doi: 10.1186/s40880-018-0274-3.
7
Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.术前预后营养指数在III期结肠癌患者中的预后价值及其与全身炎症反应标志物的相关性
Chin J Cancer. 2017 Dec 21;36(1):96. doi: 10.1186/s40880-017-0260-1.
8
Outcome of colon cancer initially presenting as colon perforation and obstruction.以结肠穿孔和梗阻为首发表现的结肠癌的转归。
World J Surg Oncol. 2017 Aug 25;15(1):164. doi: 10.1186/s12957-017-1228-y.
9
A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation.环状 RNA 通过诱导 c-myc 核转位促进肿瘤发生。
Cell Death Differ. 2017 Sep;24(9):1609-1620. doi: 10.1038/cdd.2017.86. Epub 2017 Jun 16.
10
CircRNA: functions and properties of a novel potential biomarker for cancer.环状RNA：一种新型癌症潜在生物标志物的功能与特性
Mol Cancer. 2017 May 23;16(1):94. doi: 10.1186/s12943-017-0663-2.
Zotero 插件